Can letrozole (aromatase inhibitor) cause a false‑positive urine luteinizing hormone (LH) ovulation test in women undergoing ovulation induction? | Rounds Can letrozole (aromatase inhibitor) cause a false‑positive urine luteinizing hormone (LH) ovulation test in women undergoing ovulation induction? | Rounds
Loading...

Can letrozole (aromatase inhibitor) cause a false‑positive urine luteinizing hormone (LH) ovulation test in women undergoing ovulation induction?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Urine LH ovulation test interpretation during letrozole ovulation induction

Letrozole does not have established biologic or analytic mechanisms that cause a urine LH ovulation test to become falsely positive due to assay cross-reactivity. [1] A positive urine LH ovulation test during letrozole cycles is more consistent with an endogenous LH surge driven by ovulatory physiology rather than an assay artifact. [2]

Basis of urine LH “ovulation predictor kit” results

Urine LH ovulation predictor kits detect LH in urine. [1] False-positive urine LH results in general can occur from testing conditions that trigger positive readings outside true ovulation timing. [3] Urine LH surge timing and detectability vary by test format and specimen factors. [4]

Analytic interference considerations

Urine LH kits are designed to measure LH, and the principal known cross-reactivity concern for home ovulation testing is typically pregnancy-test hCG assays, not LH assays. [1] No high-quality evidence was identified showing letrozole interferes with the antibodies or detection chemistry used by urine LH ovulation predictor kits to generate LH false positives. [2]

Biologic reasons for “positive but not followed by ovulation” patterns

Letrozole can induce follicular development and ovulatory LH physiology, which increases the likelihood of obtaining a true positive LH surge when testing is performed near the surge window. [2] Even with an LH surge, mismatch between detected LH peak and the actual time of ovulation can occur due to variability in surge-to-ovulation timing and test characteristics. [4]

Practical clinical interpretation

A positive urine LH ovulation test during letrozole treatment should generally be managed as evidence of an LH surge occurrence rather than assumed to be a false positive from letrozole. [2] If confirmation is required, serum LH or follicular assessment with ultrasound timing provides a direct assessment of the cycle’s ovulatory status. [2]

Targets and monitoring implications for ovulation induction cycles

Using urine LH kits for precise ovulation timing is limited by variability in surge detection and timing and by test performance characteristics. [3] Specimen collection timing relative to the surge, as well as creatinine adjustment and daily testing strategy, can affect detection and timing of LH surge identification. [4]

Common pitfalls to avoid

Assuming that all positive urine LH results during ovulation induction are analytic false positives can lead to under-recognition of true LH surges. [2] Interpreting a single positive qualitative test without considering test thresholds and intra-cycle variability can lead to incorrect timing of intercourse or insemination. [3]

Safety and outcome confirmation

If pregnancy has not occurred after timed intercourse or insemination, evaluation of ovulatory confirmation should focus on cycle monitoring data rather than attributing the LH kit positive result to letrozole assay interference. [2]

Related Questions